Jeffrey A. Sanford
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jeffrey A. Sanford has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Jill I. Allbritton
Dermatopathology The Joint Pathology Center Silver Spring Maryland USA
2 shared publicationsBethany M Bartlett
Naval Hospital Camp Pendelton , Camp Pendelton, CA 92055
1 shared publicationChristian A. Curcio
Soft Tissue Pathology The Joint Pathology Center Silver Spring Maryland USA
1 shared publication- Damien Abreu
Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, USA
1 shared publication Dominic M. Forte
Department of Surgery Carl R. Darnall Army Medical Center Fort Hood Texas USA
1 shared publication- Jaroslaw Jedrych
Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
1 shared publication
Latest Publications
- 24 February 2026
- Published by Springer Nature in Virchows Archiv
- p. 1-5
Cyclin D1 demonstrates superior sensitivity and consistent nuclear expression compared with MiTF in cellular neurothekeoma
Cellular neurothekeoma is an uncommon dermal neoplasm that frequently overlaps histologically with fibrohistiocytic and melanocytic tumors, particularly in superficial or limited biopsies. MiTF immunohistochemistry is commonly used for diagnostic support but shows inconsistent sensitivity with variable and often focal expression patterns, which can complicate interpretation. Cyclin D1 is a widely available nuclear marker expressed in some related fibrohistiocytic tumors, but its performance in cellular neurothekeoma has not been studied. Eleven cellular neurothekeomas diagnosed over a 7-year period were identified. Immunohistochemistry for cyclin D1 and MiTF was performed on formalin-fixed, paraffin-embedded tissue. Slides were independently scored using the blue–brown color H-score method, including assessment of overall H-scores and the proportion of tumor nuclei staining at ≥ 2+ intensity. Cyclin D1 showed consistently strong nuclear expression in all cases (11/11, 100%), with a median H-score of 205 (IQR 200–222.5), compared with 40 for MiTF (IQR 27.5–115) (p < 0.001). Strong (≥ 2+) nuclear staining was present in a median of 90% of tumor cells with cyclin D1 (IQR 82.5–100), versus 10% with microphthalmia transcription factor (IQR 0–35) (p < 0.001). MiTF was interpreted as positive in fewer than half of cases (5/11, 45%). Cyclin D1 demonstrated uniform, strong nuclear expression and superior sensitivity compared with MiTF, supporting its use as a sensitive and dependable immunohistochemical marker for cellular neurothekeoma.
- 24 February 2026
- Published by Springer Nature in Virchows Archiv
- p. 1-5
Cyclin D1 demonstrates superior sensitivity and consistent nuclear expression compared with MiTF in cellular neurothekeoma
Cellular neurothekeoma is an uncommon dermal neoplasm that frequently overlaps histologically with fibrohistiocytic and melanocytic tumors, particularly in superficial or limited biopsies. MiTF immunohistochemistry is commonly used for diagnostic support but shows inconsistent sensitivity with variable and often focal expression patterns, which can complicate interpretation. Cyclin D1 is a widely available nuclear marker expressed in some related fibrohistiocytic tumors, but its performance in cellular neurothekeoma has not been studied. Eleven cellular neurothekeomas diagnosed over a 7-year period were identified. Immunohistochemistry for cyclin D1 and MiTF was performed on formalin-fixed, paraffin-embedded tissue. Slides were independently scored using the blue–brown color H-score method, including assessment of overall H-scores and the proportion of tumor nuclei staining at ≥ 2+ intensity. Cyclin D1 showed consistently strong nuclear expression in all cases (11/11, 100%), with a median H-score of 205 (IQR 200–222.5), compared with 40 for MiTF (IQR 27.5–115) (p < 0.001). Strong (≥ 2+) nuclear staining was present in a median of 90% of tumor cells with cyclin D1 (IQR 82.5–100), versus 10% with microphthalmia transcription factor (IQR 0–35) (p < 0.001). MiTF was interpreted as positive in fewer than half of cases (5/11, 45%). Cyclin D1 demonstrated uniform, strong nuclear expression and superior sensitivity compared with MiTF, supporting its use as a sensitive and dependable immunohistochemical marker for cellular neurothekeoma.
- 15 October 2025
- Published by Oxford University Press (OUP) in Military Medicine
- Vol. 191 (7-8) , e1752-e1755
Insights From Testicular Cancer Deaths in the U.S. Military: Case Reports
Testicular cancer is the most common cause of cancer in the U.S. male active duty population. Advancements in surgical and chemotherapy approaches have led to a 95% 5-year survival rate across all stages. The United States Preventive Services Task Force recommends against non-symptomatic clinical screening or patient self-examination citing the high survival rate and overall low civilian incidence. We present 2 case reports of active duty individuals who died from complications of testicular cancer. Case 1 was found deceased. At autopsy, a pelvic mass was found disrupting the aorta along with hemoperitoneum. The mass was subsequently identified as a metastatic mixed germ cell tumor. Case 2 presented with orchalgia and a testicular mass, but did not attend to his ordered ultrasound before deployment. He returned to the United States with a >10 cm testis, widespread metastatic disease, and a serum beta-human chorionic gonadotropin (hCG) over 250,000. A non-seminomatous germ cell tumor was presumed, and an orchiectomy was delayed to initiate chemotherapy. He died shortly after therapy was initiated from a pulmonary hemorrhage. In this article, we discuss how unique features of the military population may impact testicular cancer care with evidence from these 2 cases along with suggestions where impactful change can be made.
- 15 October 2025
- Published by Oxford University Press (OUP) in Military Medicine
- Vol. 191 (7-8) , e1752-e1755
Insights From Testicular Cancer Deaths in the U.S. Military: Case Reports
Testicular cancer is the most common cause of cancer in the U.S. male active duty population. Advancements in surgical and chemotherapy approaches have led to a 95% 5-year survival rate across all stages. The United States Preventive Services Task Force recommends against non-symptomatic clinical screening or patient self-examination citing the high survival rate and overall low civilian incidence. We present 2 case reports of active duty individuals who died from complications of testicular cancer. Case 1 was found deceased. At autopsy, a pelvic mass was found disrupting the aorta along with hemoperitoneum. The mass was subsequently identified as a metastatic mixed germ cell tumor. Case 2 presented with orchalgia and a testicular mass, but did not attend to his ordered ultrasound before deployment. He returned to the United States with a >10 cm testis, widespread metastatic disease, and a serum beta-human chorionic gonadotropin (hCG) over 250,000. A non-seminomatous germ cell tumor was presumed, and an orchiectomy was delayed to initiate chemotherapy. He died shortly after therapy was initiated from a pulmonary hemorrhage. In this article, we discuss how unique features of the military population may impact testicular cancer care with evidence from these 2 cases along with suggestions where impactful change can be made.
- 25 June 2024
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 51 (10) , 742-745
Antiperspirant‐related zirconium and aluminum‐containing granulomas; histopathology and in situ chemical analysis
The potential adverse health effects of antiperspirant use are of interest to patients, primary care providers, dermatologists, and pathologists. In rare instances, antiperspirants containing aluminum–zirconium complexes have been associated with granulomatous dermatoses despite being deemed non‐sensitizing in experiments. In this case study, we present a detailed examination of an axillary granuloma in a 28‐year‐old female who had been using an aluminum–zirconium‐based antiperspirant for several years and presented with a left axillary nodule that was excised and analyzed using scanning electron microscopy with energy‐dispersive x‐ray analysis (SEM/EDXA). Histopathological examination revealed a foreign body‐type reaction with amphophilic granular material within giant cells that corresponded to collocated zirconium and aluminum on SEM/EDXA elemental maps. Our case adds to the limited reports of axillary granulomas related to aluminum–zirconium complexes. It illustrates the histopathological appearance and in situ distribution of the aluminum–zirconium complexes, supporting the formation of foreign body‐type granulomas. Additionally, our case study illustrates the potential role of these compounds in such reactions and aims to increase awareness among pathologists and clinicians.
- 25 June 2024
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 51 (10) , 742-745
Antiperspirant‐related zirconium and aluminum‐containing granulomas; histopathology and in situ chemical analysis
The potential adverse health effects of antiperspirant use are of interest to patients, primary care providers, dermatologists, and pathologists. In rare instances, antiperspirants containing aluminum–zirconium complexes have been associated with granulomatous dermatoses despite being deemed non‐sensitizing in experiments. In this case study, we present a detailed examination of an axillary granuloma in a 28‐year‐old female who had been using an aluminum–zirconium‐based antiperspirant for several years and presented with a left axillary nodule that was excised and analyzed using scanning electron microscopy with energy‐dispersive x‐ray analysis (SEM/EDXA). Histopathological examination revealed a foreign body‐type reaction with amphophilic granular material within giant cells that corresponded to collocated zirconium and aluminum on SEM/EDXA elemental maps. Our case adds to the limited reports of axillary granulomas related to aluminum–zirconium complexes. It illustrates the histopathological appearance and in situ distribution of the aluminum–zirconium complexes, supporting the formation of foreign body‐type granulomas. Additionally, our case study illustrates the potential role of these compounds in such reactions and aims to increase awareness among pathologists and clinicians.
- 12 January 2022
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 49 (6) , 570-574
Cutaneous Gamna‐Gandy bodies: An unusual case of dystrophic calcification
Dystrophic calcification is a common histopathologic finding that can be concomitant with a plethora of diseases, ranging from self-limited infections to insidious malignancies. Gamna-Gandy bodies (GGBs) are a form of dystrophic calcification associated with chronic hemolysis and are typically observed in the spleen. In this report, we present a case of a 92-year-old man who presented with a four-millimeter blue papule that was biopsied given the concern for a blue nevus. The subsequent histopathological examination of the biopsy specimen showed a dermal organizing hematoma adjacent to pale yellow to brown, refractile material within fibrotic collagen consistent with GGBs. Scanning electron microscopy with energy dispersive x-ray analysis (SEM/EDXA) revealed that the structures were composed of carbon (39%), oxygen (32%), iron (16%), phosphorus (7%), calcium (5%), and sodium (1%). Fourier transform infrared spectroscopy (FTIR) identified amorphous calcium phosphate. GGBs have not been previously described in the skin and have been rarely characterized with SEM/EDXA in other sites.
- 12 January 2022
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 49 (6) , 570-574
Cutaneous Gamna‐Gandy bodies: An unusual case of dystrophic calcification
Dystrophic calcification is a common histopathologic finding that can be concomitant with a plethora of diseases, ranging from self-limited infections to insidious malignancies. Gamna-Gandy bodies (GGBs) are a form of dystrophic calcification associated with chronic hemolysis and are typically observed in the spleen. In this report, we present a case of a 92-year-old man who presented with a four-millimeter blue papule that was biopsied given the concern for a blue nevus. The subsequent histopathological examination of the biopsy specimen showed a dermal organizing hematoma adjacent to pale yellow to brown, refractile material within fibrotic collagen consistent with GGBs. Scanning electron microscopy with energy dispersive x-ray analysis (SEM/EDXA) revealed that the structures were composed of carbon (39%), oxygen (32%), iron (16%), phosphorus (7%), calcium (5%), and sodium (1%). Fourier transform infrared spectroscopy (FTIR) identified amorphous calcium phosphate. GGBs have not been previously described in the skin and have been rarely characterized with SEM/EDXA in other sites.
- 2 November 2021
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 44 (4) , 272-275
Cutaneous Actinomycosis of the Perineum in an Immunocompetent Man
We present a case of primary cutaneous actinomycosis of unclear pathogenesis. A 30-year-old-man with no significant medical or surgical history presented to the emergency department with a 2-week history of a tender perineal mass. The patient denied trauma or perforating injury to the area. Examination of the area revealed an indurated, nonfluctuant, erythematous papulonodule located 2 cm from the anus. The lesion was unresponsive to oral and topical antibiotics and was therefore excised. The excision specimen revealed a dense mixed infiltrate partially filling the reticular dermis and extending into the subcutaneous fat. The infiltrate surrounded grains of basophilic material with an outer rim of eosinophilic radiating Splendore–Hoeppli material. Within the grains, filamentous bacteria were highlighted with Periodic acid-Schiff and Grocott's methenamine silver. The organisms were gram-positive and acid-fast negative. Given the clinical and histopathologic findings, actinomycosis was diagnosed. Two weeks later, the patient reported resolution of symptoms. The patient was lost to follow-up. This case highlights an unusual presentation of actinomycosis and the crucial role histopathology plays in diagnosis.
- 2 November 2021
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 44 (4) , 272-275
Cutaneous Actinomycosis of the Perineum in an Immunocompetent Man
We present a case of primary cutaneous actinomycosis of unclear pathogenesis. A 30-year-old-man with no significant medical or surgical history presented to the emergency department with a 2-week history of a tender perineal mass. The patient denied trauma or perforating injury to the area. Examination of the area revealed an indurated, nonfluctuant, erythematous papulonodule located 2 cm from the anus. The lesion was unresponsive to oral and topical antibiotics and was therefore excised. The excision specimen revealed a dense mixed infiltrate partially filling the reticular dermis and extending into the subcutaneous fat. The infiltrate surrounded grains of basophilic material with an outer rim of eosinophilic radiating Splendore–Hoeppli material. Within the grains, filamentous bacteria were highlighted with Periodic acid-Schiff and Grocott's methenamine silver. The organisms were gram-positive and acid-fast negative. Given the clinical and histopathologic findings, actinomycosis was diagnosed. Two weeks later, the patient reported resolution of symptoms. The patient was lost to follow-up. This case highlights an unusual presentation of actinomycosis and the crucial role histopathology plays in diagnosis.